Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial
- 3 January 2006
- journal article
- other
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (1) , 205-207
- https://doi.org/10.1016/j.jacc.2005.10.016
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Risk of Thrombosis With the Use of Sirolimus-Eluting Stents for Percutaneous Coronary Intervention (from Registry and Clinical Trial Data)The American Journal of Cardiology, 2005
- Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting StentsJournal of the American College of Cardiology, 2005
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-eluting stents vs. standard stents in patients with stenosis in a native coronary arteryACC Current Journal Review, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Argentine randomized study: coronary angioplasty with stenting vs. coronary artery bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one year follow-up resultsACC Current Journal Review, 2001
- Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary ArteriesCirculation, 2001
- Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up resultsJournal of the American College of Cardiology, 2001